Board Moves.

Agenus (NASDAQ: AGEN)

Appoints Jennifer Buell to the Board of Directors. Ms. Buell is the Chief Executive Officer at MiNK Therapeutics.

Amarin (NASDAQ: AMRN)

Aaron Berg promoted to CEO and he is appointed to the Board of Directors.

Arcturus Therapeutics (NASDAQ: ARCT)

Appoints Moncef Slaoui to the Board of Directors. Mr. Slaoui is a former Partner at Medicxi.

Ascend Wellness (OTCMKTS: AAWH)

Appoints Julie Francis to the Board of Directors. Ms. Francis is the Chief Operating Officer at The Schwan’s Company.

bluebird bio (NASDAQ: BLUE)

Appoints Michael Cloonan to the Board of Directors. Mr. Cloonan is theChief Executive Officer at Sionna Therapeutics.

Bristol-Myers Squibb (NYSE: BMY)

Appoints Michael McMullen to the Board of Directors. Mr. McMullen is the former Chief Executive Officer at Agilent.

Coherus BioSciences (NASDAQ: CHRS)

Appoints Rita Karachun to the Board of Directors. Ms. Karachun is the former Global Controller at Merck & Co.

Contineum Therapeutics (NASDAQ: CTNM)

Appoints Sarah Boyce to the Board of Directors. Ms. Boyce is the CEO at Avidity Biosciences.

Fulcrum Therapeutics (NASDAQ: FULC)

Appoints Colin Hill to the Board of Directors. Mr. Hill is the Co-Founder and Chief Executive Officer at Aitia

Herbalife (NYSE: HLF)

Appoints Perkins Miller to the Board of Directors. Mr. Miller is the Chief Executive Officer at Fandom.

Intellia Therapeutics (NASDAQ: NTLA)

Appoints Brian Goff to the Board of Directors. Mr. Goff is the Chief Executive Officer at Agios Pharmaceuticals.

Jasper Therapeutics (NASDAQ: JSPR)

Appoints Svetlana Lucas to the Board of Directors. Ms. Lucas is the Chief Business Officer at Scribe Therapeutics.

Keros Therapeutics (NASDAQ: KROS)

Jasbir Seehra promoted to Chair of the Board. Jasbir is the Chief Executive Officer at Keros Therapeutics.

McKesson (NYSE: MCK)

Appoints Deborah Dunsire to the Board of Directors. Ms. Dunsire is the former Chief Executive Officer at H Lundbeck A/S.

Mineralys Therapeutics (NASDAQ: MLYS)

Appoints Alexander Gold to the Board of Directors. Mr. Gold is the Chief Medical Officer at Beren Therapeutics.

NRx Pharmaceuticals (NASDAQ: NRXP)

Appoints Dennis McBride to the Board of Directors. Mr. McBride is a Professor at Virginia Tech.

Pliant Therapeutics (NASDAQ: PLRX)

Appoints Steve Krognes to the Board of Directors. Mr. Krognes is the former Chief Financial Officer at Denali Therapeutics.

Regenxbio (NASDAQ: RGNX)

Curran Simpson promoted to CEO and he is appointed to the Board of Directors.

SeaStar Medical (NASDAQ: ICU)

Appoints Jennifer Baird, Bernadette Vincent and John Neuman to the Board of Directors. Ms. Baird is the Executive Chair of the Board at Culturewell, Ms. Vincent is the former COO at Satellite Healthcare and Mr.Neuman is the former VP Global Financial Accounting at Dow Chemical.

Summit Therapeutics (NASDAQ: SMMT)

Appoints Jeff Huber to the Board of Directors. Mr. Huber is the Co-Founder at Triatomic Capital.

Teladoc Health (NYSE: TDOC)

Charles Divita named CEO and he is appointed to the Board of Directors. Mr. Divita is the former Executive Vice President, Commercial Markets GuideWell Mutual.

Tscan Therapeutics (NASDAQ: TCRX)

Appoints Garry Nicholson to the Board of Directors. Mr. Nicholson is the former President, Oncology at Pfizer.

Verve Therapeutics (NASDAQ: VERV)

Appoints Nia Tatsis and Jodie Morrison to the Board of DIrectors. Ms. Tatsisis the Chief Regulatory & Quality Officer at Vertex Pharma and Ms. Morrison is the CEO at Q32 Bio.

Zentalis Pharmaceuticals (NASDAQ: ZNTL)

Appoints Luke Walker to the Board of Directors. Mr. Walker is the Chief Medical Officer at Harpoon Therapeutics.

Zimmer Biomet (NYSE: ZBH)

Appoints Devdatt Kurdikar to the Board of Directors. Mr. Kurdikar is the Chief Executive Officer at Embecta.

‍

‍

Agilon Health (NYSE: AGL)

Jeff Schwaneke resigns from the Board of Directors. Mr. Schwaneke is the Chief Financial Officer at Agilon Health.

Alphatec (NASDAQ: ATEC)

Elizabeth Altman, Marie Meynadier, David Mowry, and James Tullis to leave the Board of Directors. Ms. Altman is a former Partner at KPMG,Ms. Meynadier is the Founder at EOS Imaging SA, Mr. Mowry is the former CEO at Cutera, and Mr. Tullis is the Founding Partner at Tullis Health Investors,

AxoGen (NASDAQ: AXGN)

Gregory Freitag departs the Board of Directors. Mr. Freitag is the former General Counsel at AxoGen.

Brookdale Senior Living (NYSE: BKD)

Guy Sansone and Marcus Bromley retire from the Board of Directors. Mr. Sansone is the Non-Executive Chair of the Board at Brookdale Senior Living and Mr. Bromley is the former Chair of the Board and CEO at Gables Residential Trust.

Editas Medicine (NASDAQ: EDIT)

Akshay Vaishnaw resigns from the Board of DIrectors. Mr. Vaishnaw is the Chief Innovation Officer at Alnylam Pharmaceuticals.

Kymera Therapeutics (NASDAQ: KYMR)

Joanna Horobin resigns from the Board of Directors. Ms. Horobin is the former Chief Medical Officer at Idera Pharmaceuticals.

Maravai LifeSciences (NASDAQ: MRVI)

Anat Ashkenazi resigns from the Board of Directors. Ms. Ashkenazi is the CFO-elect at Alphabet.

Pulse Biosciences (NASDAQ: PLSE)

Shelley Spray leaves the Board of Directors. Ms. Spray is the Head of Marketing at Summit Therapeutics.

Summit Therapeutics (NASDAQ: SMMT)

Ujwala Mahatme resigns from the Board of Directors. Ms. Mahatme is the Managing Partner at Mahatme Bitterman.

Tenaya Therapeutics (NASDAQ: TNYA)

Jin-Long Chen resigns from the Board of Directors. Mr. Chen is the Managing Partner & Chief Executive Officer at TCG Labs-Soleil.